GSK Remains Open To Consumer Healthcare Sale As It Prepares To Name CEO

Responding directly to a call from an activist investor to consider selling Consumer Healthcare, GSK says it will evaluate any acquisition proposals it receives. A six-month long process to appoint a CEO to lead the new standalone OTC business is also nearing its conclusion.